Table 1.

Baseline demographic and details of the treatment data of the study cohort

Patient No.	Therapeutic success	Age, sex	Diagnosis	Leak size, cm	Cavity size, cm	Latency of stenting, days	Treatment before stenting	Distance from the teeth, cm	VACStent treatments, n	Negative pressure, mm Hg	Total duration of VACStent treatment, days	VACStent complication	Oral intake	Drainage and other management	Treatment change
1	Yes	58, M	Anastomotic leak after gastrectomy	2	3	0	EVT	40	1	125	4	Lost sponge, small diameter	No	1× pleural drainage; NGT; AB	None
2	Yes	61, M	Anastomotic leak after gastrectomy	1	3	0	OTSC	40	2	125	6	Small diameter	Yes, only liquids	1× pleural drainage; AB	None
3	Yes	30, F	Boerhaave syndrome	1	2	0	EVT	38–39	3	125	18	Small diameter	Yes, only liquids	1× pleural drainage; NGT; AB	None
4	Yes	78, M	Leak of the suturing line after esophago-respiratory fistula	2	No	1	None	36–38	1	125	5	Lost sponge, small diameter	No	1× pleural drainage; NGT; AB	None
5	Yes	75, M	Anastomotic leak after gastrectomy	3	3	0	None	40	1	125	5	Small diameter	Yes, only liquids	1× pleural drainage; NGT; AB	None
6	Yes	28, M	Esophageal fistula	0.5	Fistula	7	None	34	1	125	5	Small diameter	Yes, only liquids	AB	None
7	Yes	64, M	Anastomotic leak after esophagectomy	1	2	0	None	25	1	125	4	Small diameter	No	1× pleural drainage; NGT; AB	None
8	No	84, F	Iatrogenic perforation after transesophageal ultrasound	1	4	3	OTSC	24	2	125	7	Lost sponge, small diameter	No	1× pleural drainage; AB	Eso-SPONGE®
9	No	58, M	Esophageal fistula after esophagectomy	0.5	Fistula	83	SEMS	30	2	125	6	Small diameter	No	1× pleural drainage; AB	EsoSPONGE®
10	No	65, M	Boerhaave syndrome	2	3	3	None	38	1	125	3	Small diameter	No	1× pleural drainage; NGT; AB	Surgery